Barclays analysts initiated coverage on Insmed Incorporated (NASDAQ:INSM) with a Overweight rating on January 28, 2026.
Insmed Incorporated operates in the Healthcare sector. The stock currently trades at $156.87 with a market capitalization of $41.6B.


